Cubist Systematic Strategies’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-47,387
| Closed | -$2.49M | – | 2816 |
|
|
2020
Q3 | $2.49M | Sell |
47,387
-25,902
| -35% | -$1.07M | 0.04% | 775 |
|
|
2020
Q2 | $2.44M | Buy |
73,289
+46,083
| +169% | +$1.47M | 0.04% | 668 |
|
|
2020
Q1 | $740K | Sell |
27,206
-40,019
| -60% | -$1.11M | 0.02% | 1022 |
|
|
2019
Q4 | $1.33M | Buy |
67,225
+34,770
| +107% | +$556K | 0.02% | 984 |
|
|
2019
Q3 | $421K | Sell |
32,455
-23,202
| -42% | -$280K | 0.01% | 1381 |
|
|
2019
Q2 | $693K | Buy |
+55,657
| New | +$739K | 0.01% | 1265 |
|
|
2019
Q1 | – | Sell |
-53,261
| Closed | -$588K | – | 2501 |
|
|
2018
Q4 | $588K | Buy |
+53,261
| New | +$741K | 0.03% | 861 |
|
|
2018
Q1 | – | Sell |
-100
| Closed | -$1K | – | 2174 |
|
|
2017
Q4 | $1K | Buy |
+100
| New | +$1.35K | ﹤0.01% | 1872 |
|
|
2016
Q1 | – | Sell |
-17,992
| Closed | -$267K | – | 1931 |
|
|
2015
Q4 | $267K | Buy |
+17,992
| New | +$301K | 0.02% | 1185 |
|
|
2015
Q3 | – | Sell |
-17,236
| Closed | -$393K | – | 2092 |
|
|
2015
Q2 | $393K | Sell |
17,236
-3,620
| -17% | -$72.1K | 0.02% | 1071 |
|
|
2015
Q1 | $317K | Buy |
+20,856
| New | +$271K | 0.02% | 1225 |
|
|
2014
Q4 | – | Sell |
-10,300
| Closed | -$117K | – | 2110 |
|
|
2014
Q3 | $117K | Buy |
10,300
+8,100
| +368% | +$92.4K | 0.01% | 1515 |
|
|
2014
Q2 | $27K | Buy |
+2,200
| New | +$26K | ﹤0.01% | 1445 |
|
Cubist Systematic Strategies's MNTA Position: Q4 2020 in Review
Cubist Systematic Strategies sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 47,387 shares — an estimated $2.49M sold.
Cubist Systematic Strategies first reported a position in MNTA in Q2 2014 and held it in 13 quarters. The position peaked at $2.49M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Cubist Systematic Strategies reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Cubist Systematic Strategies sold 47,387 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $2.49M.
- Cubist Systematic Strategies first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2014 and held it in 13 quarters.
- Cubist Systematic Strategies's Momenta Pharmaceuticals, Inc. position peaked at $2.49M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Cubist Systematic Strategies's 13F filing for Q4 2020, filed 16 Feb 2021.